Min.Order / FOB Price:Get Latest Price
1 Gram |
FOB Price:USD 40.0000 -50.0000 |
477600-75-2 Antineoplastic Agents Pharmaceuticals
About us
Our company has been in existence for 10 years since its establishment. We have our own unique team. The company integrates independent research and development, production and sales. We have established famous brands at home and abroad. At present, our customers have spread all over the world, we have rich Transportation experience, we aim to serve customers, to help customers, solve problems for customers. Look forward to working with you!
Product name
Tofacitinib CAS:477600-75-2
Packaging, Storage &Shelf Life
Package
1kg/bag,25kg/ drum
Storage
Stored in original packaging for two years at a temperature not exceeding 40°C.
Shelf life
2 years if sealed and stored properly.
Specification
Item |
Specification |
Specific rotation |
+39.5 to +41.5° |
State of solution(transmittance) |
Clear 98.0% min. |
Chloride[cl] |
0.020% max. |
Ammonium [NH4] |
0.02% max. |
Sulfate[SO4] |
0.020% max |
Iron[Fe] |
10ppm max. |
Heavy metals [Pb] |
10ppm max |
Arsenic[As2O3] |
1ppm max |
Other amino acids |
Chromatographically not detectable |
Loss on drying |
0.20% max. |
Residue on ignition[sulfated] |
0.10% max. |
Assay |
99.0% min |
Function
It is an inhibitor of the enzyme janus kinase 1 (JAK1) and janus kinase 3 (JAK 3) , which means that it interferes with the JAK-STAT signaling pathway, which transmits extracellular information into the cell nucleus, influencingDNA transcription.
In a mouse model of established arthritis, tofacitinib rapidly improved disease by inhibiting the production of inflammatory mediators and suppressing STAT1-dependent genes in joint tissue. This efficacy in this disease model correlated with the inhibition of both JAK1 and 3 signaling pathways, suggesting that tofacitinib may exert therapeutic benefit via pathways that are not exclusive to inhibition of JAK3.
Application
New oral drugs for the occasional method, (tofacitinib the introduction) to selectively inhibit JAK3 signal transduction pathways in cells, inhibition of CD4 T cell proliferation, further blocking interleukin (IL) 17, a gamma interferon, IL - 6, IL - 8 synthesis and secretion of cytokines, such as inhibition of patients with RA synovial fibroblasts proliferation and damaged cartilage further damage.Jak kinase inhibitors, the treatment of rheumatoid arth.
CAS NO:51446-62-9
CAS NO:62-31-7
CAS NO:53-86-1
CAS NO:2530-83-8
CAS NO:75980-60-8
CAS NO:540737-29-9
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View